Arrowhead Pharmaceuticals (ARWR) Total Debt (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Total Debt of $199.6 million for Q1 2026, down 1.71% on a QoQ basis from $203.1 million in Q4 2025, and down 27.12% year-over-year from $273.9 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Total Debt (2011 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Total Debt history runs 10 years deep, the most recent figure standing at $199.6 million for Q1 2026.
- Quarterly Total Debt fell 27.12% year-over-year to $199.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.6 million (down 27.12% YoY) and the FY2025 annual result came in at $254.9 million, down 35.17% from the prior year.
- Total Debt was $199.6 million for Q1 2026 at Arrowhead Pharmaceuticals, down from $203.1 million in the prior quarter.
- Across five years, Total Debt topped out at $409.4 million in Q4 2024 and bottomed at $199.6 million in Q1 2026.
- A 3-year average of $282.1 million and a median of $254.9 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2025 — Total Debt slumped 50.39% — and 2026, when it retreated 27.12%.
- Arrowhead Pharmaceuticals' Total Debt stood at $409.4 million in 2024, then slumped by 50.39% to $203.1 million in 2025, then dropped by 1.71% to $199.6 million in 2026.
- Business Quant data shows ARWR's Total Debt at $199.6 million in Q1 2026, $203.1 million in Q4 2025, and $254.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | 199.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 199.64 Mn |
| Dec 31, 2025 | 203.11 Mn |
| Sep 30, 2025 | 254.88 Mn |
| Jun 30, 2025 | 240.33 Mn |
| Mar 31, 2025 | 273.93 Mn |
| Dec 31, 2024 | 409.41 Mn |
| Sep 30, 2024 | 393.18 Mn |
| Sep 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | 2.70 Mn |
| Mar 31, 2019 | 2.70 Mn |
| Dec 31, 2018 | 2.30 Mn |
| Sep 30, 2018 | 2.10 Mn |
| Jun 30, 2018 | 2.16 Mn |
| Mar 31, 2018 | 2.22 Mn |
| Dec 31, 2017 | 2.27 Mn |
| Sep 30, 2017 | 2.33 Mn |
| Jun 30, 2017 | 2.38 Mn |
| Mar 31, 2017 | 2.43 Mn |
| Dec 31, 2016 | 2.48 Mn |
| Sep 30, 2016 | 2.53 Mn |